Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)
The main goal of this study is to improve dysexecutive symptoms (e.g., sustained attention, processing speed) in patients exhibiting post-acute sequelae of COVID-19 (PASC) through home-based transcranial direct current stimulation (tDCS), a noninvasive method that uses low intensity electric currents delivered to the brain through stimulation electrodes on the scalp.
Conditions:
🦠 Dysexecutive Syndrome 🦠 Post-Acute Sequelae of COVID-19
🗓️ Study Start (Actual) 7 June 2022
🗓️ Primary Completion (Estimated) 31 August 2024
✅ Study Completion (Estimated) 31 August 2024
👥 Enrollment (Estimated) 40
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Charlestown, Massachusetts, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Ability to provide informed consent
    • * A diagnosis of PASC as indicated by past COVID-19 infection, and persistent symptoms, including 'brain fog', confusion, short-term memory deficits, trouble concentrating, delirium, difficulties in multitasking.

    Exclusion Criteria:

    • * History of epilepsy
    • * Metallic implants in the head and neck,
    • * Brain stimulators
    • * Pacemakers
    • * Pregnancy
    • * Active substance dependence (except for tobacco)
    • * Premorbid major neurological illness
    • * Severe mental illness (e.g., bipolar disorder, schizophrenia)
    • * Attention Deficit Hyperactivity Disorder
Ages Eligible for Study: 18 Years to 65 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 21 October 2021
  • First Submitted that Met QC Criteria 21 October 2021
  • First Posted 25 October 2021

Study Record Updates

  • Last Update Submitted that Met QC Criteria 8 May 2024
  • Last Update Posted 9 May 2024
  • Last Verified May 2024